Clinical, physiological, imaging and molecular responses to cannabis smoking: the Canadian Users of Cannabis Smoke (CANUCK) study
European Respiratory Journal · 2026-01 · 67 (1) · 2501659
DOI: 10.1183/13993003.01659-2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 06.11.2025. Verfasst von Clarus Leung und 26 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada. Hauptthemen laut MEDLINE: Marijuana Smoking, Lung. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
Background
The growing popularity of cannabis smoking in an era of legalisation has prompted concerns about respiratory health.
Objective
To investigate clinical and airway epithelial transcriptomic features associated with cannabis smoking.
Methods
This cross-sectional study analysed data from 139 cannabis-smoking participants categorised by joint-year exposure (low: ≤5; moderate: >5–20; high: >20 joint-years) and 57 never-smokers. We evaluated respiratory symptom questionnaire scores, lung function measurements, chest computed tomography and hyperpolarised 129 Xenon pulmonary magnetic resonance imaging measurements across groups. We compared the expression of immune response signatures and mucin genes in airway epithelial brushings collected from bronchoscopy. Using air–liquid interface cell cultures, we quantified epithelial mucin 5AC (MUC5AC) protein and correlated its expression with clinical outcomes.
Results
Among cannabis-smoking participants (48% male, median age of 27 years), 84% reported current or former cigarette smoking or vaping. Cannabis-smoking groups reported worse respiratory symptoms than never-smokers. High joint-year cannabis-smoking participants showed lower pre-bronchodilator forced expiratory volume in 1 s to forced vital capacity ratio, lower forced expiratory flow at 25–75% of the forced vital capacity, more radiographic emphysema and more ventilation abnormalities than never-smokers. Airway epithelial brushings from cannabis-smoking participants demonstrated an increased type 2 immune response, decreased type 17 immune response and higher MUC5AC gene expression than non-cannabis-smoking participants. Epithelial MUC5AC protein expression in cell cultures correlated with worse clinical outcomes and imaging abnormalities.
Conclusions
Cannabis smoking, particularly at high exposures, is associated with worse respiratory symptoms, lower lung function, functional imaging abnormalities and dysregulated immune responses in the airway epithelium. These observations suggest respiratory harm associated with cannabis smoking and underscore the concerns for future respiratory morbidities related to persistent cannabis use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada.
- Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
- Co-first authors.
- Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Department of Radiology, University of British Columbia, Vancouver, BC, Canada.
ORCID-Profile: Clarus Leung, Xuan Li, Jonathan H Rayment, Miranda Kirby, Andrea S Gershon, Mohsen Sadatsafavi, Grace Parraga, Christopher Carlsten, Rachel L Eddy
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Leung, C., Gilchrist, C. L., Wang, C. J., Liggins, J. A., Li, X., Yang, J., Cheung, C. Y., Gerayeli, F. V., Singhera, G. K., Hsu, W. J., Lidher, L. S., Moo, K., Leyson, E., Dhillon, S. S., Shaipanich, T., Leipsic, J. A., Guenette, J. A., Rayment, J. H., Kirby, M., …, & Leung, J. M. (2026). Clinical, physiological, imaging and molecular responses to cannabis smoking: the Canadian Users of Cannabis Smoke (CANUCK) study. European Respiratory Journal, 67(1), 2501659. https://doi.org/10.1183/13993003.01659-2025
Vancouver
Leung C, Gilchrist CL, Wang CJ, Liggins JA, Li X, Yang J, et al. Clinical, physiological, imaging and molecular responses to cannabis smoking: the Canadian Users of Cannabis Smoke (CANUCK) study. European Respiratory Journal. 2026;67(1):2501659. doi:10.1183/13993003.01659-2025
BibTeX
@article{Leung2026,
author = {Leung, Clarus and Gilchrist, Cassie L and Wang, Carolyn J and Liggins, James A and Li, Xuan and Yang, Julia and Cheung, Chung Y and Gerayeli, Firoozeh V and Singhera, Gurpreet K and Hsu, Wu Jih and Lidher, Lavraj S and Moo, Karolina and Leyson, Eleazar and Dhillon, Satvir S and Shaipanich, Tawimas and Leipsic, Jonathon A and Guenette, Jordan A and Rayment, Jonathan H and Kirby, Miranda and Gershon, Andrea S and Sadatsafavi, Mohsen and Tan, Wan C and Parraga, Grace and Carlsten, Christopher and Eddy, Rachel L and Sin, Don D and Leung, Janice M},
title = {Clinical, physiological, imaging and molecular responses to cannabis smoking: the Canadian Users of Cannabis Smoke (CANUCK) study},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {1},
pages = {2501659},
doi = {10.1183/13993003.01659-2025}
}
EUVIMED